Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Sclerotinia sclerotiorum Autophagy-related protein 22-1 (atg22-1), partial CSB-YP413895STG
CSB-EP413895STG
CSB-BP413895STG
CSB-MP413895STG
CSB-EP413895STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Long chronological lifespan protein 2 (lcl2) CSB-YP413896STG
CSB-EP413896STG
CSB-BP413896STG
CSB-MP413896STG
CSB-EP413896STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Probable endonuclease lcl3 (lcl3), partial CSB-YP413897STG1
CSB-EP413897STG1
CSB-BP413897STG1
CSB-MP413897STG1
CSB-EP413897STG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Sensitive to high expression protein 9 homolog, mitochondrial (she9), partial CSB-YP413898STG
CSB-EP413898STG
CSB-BP413898STG
CSB-MP413898STG
CSB-EP413898STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Pre-mRNA-splicing ATP-dependent RNA helicase prp28 (prp28), partial CSB-YP413899STG
CSB-EP413899STG
CSB-BP413899STG
CSB-MP413899STG
CSB-EP413899STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Methylthioribulose-1-phosphate dehydratase (mde1) CSB-YP413900STG
CSB-EP413900STG
CSB-BP413900STG
CSB-MP413900STG
CSB-EP413900STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Mitochondrial distribution and morphology protein 12 (mdm12) CSB-YP413901STG
CSB-EP413901STG
CSB-BP413901STG
CSB-MP413901STG
CSB-EP413901STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum rRNA-processing protein efg1 (efg1) CSB-YP413902STG
CSB-EP413902STG
CSB-BP413902STG
CSB-MP413902STG
CSB-EP413902STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Putative DNA helicase INO80 (INO80), partial CSB-YP413903STG
CSB-EP413903STG
CSB-BP413903STG
CSB-MP413903STG
CSB-EP413903STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum ATP-dependent RNA helicase CHL1 (CHL1), partial CSB-YP413904STG
CSB-EP413904STG
CSB-BP413904STG
CSB-MP413904STG
CSB-EP413904STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Mitochondrial division protein 1 (mdv1), partial CSB-YP413905STG
CSB-EP413905STG
CSB-BP413905STG
CSB-MP413905STG
CSB-EP413905STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Lipoyl synthase, mitochondrial (SS1G_09179) CSB-YP413906STG
CSB-EP413906STG
CSB-BP413906STG
CSB-MP413906STG
CSB-EP413906STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Mitochondrial distribution and morphology protein 34 (mdm34), partial CSB-YP413907STG
CSB-EP413907STG
CSB-BP413907STG
CSB-MP413907STG
CSB-EP413907STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum 54S ribosomal protein L4, mitochondrial (MRPL4), partial CSB-YP413908STG
CSB-EP413908STG
CSB-BP413908STG
CSB-MP413908STG
CSB-EP413908STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Fe-S cluster assembly protein dre2 (dre2) CSB-YP413909STG
CSB-EP413909STG
CSB-BP413909STG
CSB-MP413909STG
CSB-EP413909STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum U3 small nucleolar RNA-associated protein 25 (utp25), partial CSB-YP413910STG
CSB-EP413910STG
CSB-BP413910STG
CSB-MP413910STG
CSB-EP413910STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum High osmolarity signaling protein sho1 (sho1), partial CSB-YP413911STG1
CSB-EP413911STG1
CSB-BP413911STG1
CSB-MP413911STG1
CSB-EP413911STG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum 40S ribosomal protein S0 (rps0) CSB-YP413912STG
CSB-EP413912STG
CSB-BP413912STG
CSB-MP413912STG
CSB-EP413912STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Adenylyltransferase and sulfurtransferase uba4 (uba4) CSB-YP413913STG
CSB-EP413913STG
CSB-BP413913STG
CSB-MP413913STG
CSB-EP413913STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum tRNA (guanine-N (7)-)-methyltransferase subunit trm82, partial CSB-YP413914STG
CSB-EP413914STG
CSB-BP413914STG
CSB-MP413914STG
CSB-EP413914STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>